might be different markets. Increase in FPH consumables are for hospital based devices for respiratory failure in acute diseases (eg COVID)whereas RMD for home based devices for sleep apnoea.
Ann: Fisher & Paykel Healthcare provides FY21 trading update, page-10
Add FPH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$26.57 |
Change
0.370(1.41%) |
Mkt cap ! $15.51B | |||
| Open | High | Low | Value | Volume |
| $26.27 | $26.65 | $26.25 | $6.267M | 236.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2327 | $26.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $26.59 | 2900 | 2 |
View Market Depth
| Last trade - 16.10pm 08/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$26.64 |
Change
0.370 ( 1.18 %) |
||||
| Open | High | Low | Volume | ||
| $26.28 | $26.64 | $26.28 | 26338 | ||
| Last updated 15.59pm 08/05/2024 ? | |||||
| FPH (ASX) Chart |